This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ONLINE REGISTRATION CLOSES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Naveen Mehta, Ph.D.
Director of Preclinical Research and Development at Cullinan Oncology

Profile


Naveen Mehta is Director of Preclinical Research and Development at Cullinan Oncology, where he has been for the past two years. Prior to his time at Cullinan, Naveen completed his PhD at MIT in the department of Biological Engineering, where he worked with Profs. Darrell Irvine and Dane Wittrup to engineer potent lymph node-targeted protein-based vaccines. This work has thus far contributed to ten academic papers and patented technology.

Agenda Sessions

  • Intratumoral Administration and Retention of IL-2 and IL-12 Bifunctional Fusion Proteins to Drive a Systemic Immune Response

    3:00pm